
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Singular Genomics Systems Inc
Singular Genomics Systems, Inc. operates as a life science technology company. The Company develops novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Singular Genomics Systems serves customers worldwide.
Stock Analysis

last close
$4.34
1-mo return
2.6%
3-mo return
9%
avg daily vol.
148.68T
52-week high
18.92
52-week low
2.66
market cap.
$306M
forward pe
-
annual div.
-
roe
-79.4%
ltg forecast
18.8%
dividend yield
-
annual rev.
$--
inst own.
71.2%